Alector Inc. Comparables
Find the most relevant public market comparables for Alector Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Alector Inc. is a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegenerative diseases, such as frontotemporal dementia, Alzheimer's disease, Parkinson's disease, and Lewy body dementia. The company leverages genetics, immunology, and neuroscience to advance a portfolio of genetically-validated programs aimed at removing toxic proteins, replacing deficient proteins, and restoring immune and nerve cell function.
Business Model
Alector develops and commercializes novel therapeutic approaches for the treatment of neurodegeneration by focusing on immuno-neurology. This involves identifying and developing antibody drugs targeting neuroimmune targets to restore healthy immune function in the brain.
Target Customers
Pharmaceutical companies (for partnerships and collaborations), patients suffering from neurodegenerative diseases.
Specific Focus
Immuno-neurology; development of therapies for neurodegenerative diseases.
Location
South San Francisco, California
CEO
Arnon Rosenthal, Ph.D.
Industry
Life sciences
Sub Sector
Biotechnology
3yr Revenue Growth
360%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Alector Inc. in the Healthcare sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Alector Inc.? Our platform provides detailed analysis of Alector Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Alector Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Alector Inc. Compset
As a leading player in the Life sciences industry within the Healthcare sector, Alector Inc. operates in the specialized Biotechnology sub-sector. Understanding how Alector Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Alector Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free